18
Participants
Start Date
October 31, 2016
Primary Completion Date
April 30, 2021
Study Completion Date
May 31, 2022
Syntocinon
The active substance of Syntocinon is a synthetic nonapeptide identical to the posterior pituitary hormone oxytocin.
Placebo (for Syntocinon)
The placebo is identical to the Syntocinon formulation with the exception of the active compound, i.e., without oxytocin.
Children's Hospital of Philadelphia, Philadelphia
Shana McCormack, MD
OTHER